Inhibitor Therapeutics, Inc. Operating Lease Right-of-Use Assets
Inhibitor Therapeutics, Inc. (INTI) had Operating Lease Right-of-Use Assets of $50.38 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-14
- 2026-06-30: Operating Lease, Right-of-Use Asset $50.38K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $57.41K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $64.31K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $71.08K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $50.38K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $57.41K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $64.31K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $71.08K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $77.73K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $84.27K 10-Q · filed 2025-05-14 |